NICE backs daratumumab quadruplet for newly diagnosed transplant‑ineligible myeloma
11th June 2026 Uncategorised 0
Final draft guidance recommends D‑VRd on the NHS in England and Wales

More: NICE backs daratumumab quadruplet for newly diagnosed transplant‑ineligible myeloma
Source: News
